Protagonist Therapeutics (PTGX) Revenue (2015 - 2026)
Protagonist Therapeutics (PTGX) revenue from Jun 30, 2015 to Mar 31, 2026. The TTM Protagonist Therapeutics (PTGX) revenue is $74M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Protagonist Therapeutics (PTGX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -64.36% |
| 3 Years TTM | +341.62% |
| 5 Years TTM | +16.30% |
Annual Revenue change of Protagonist Therapeutics (PTGX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $56M | +22.49% |
| 2025 | $46M | -89.41% |
| 2024 | $434M | +624.05% |
| 2023 | $60M | +125.73% |
| 2022 | $27M | -2.85% |
| 2021 | $27M | -4.44% |
| 2020 | $29M | +12347.83% |
| 2019 | $230K | -99.26% |
| 2018 | $31M | +54.19% |
| 2017 | $20M | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
Comparison Protagonist Therapeutics (PTGX) five years revenue CAGR with competitors
Protagonist Therapeutics (PTGX) five years revenue CAGR is 16.30%.